Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Sales | 673,871 | 527,038 | 414,374 | 223,645 | 160,056 |
| Cost of Goods | 417,663 | 339,049 | 269,585 | 147,253 | 100,730 |
| Gross Profit | 253,738 | 187,989 | 133,246 | 59,876 | 59,326 |
| Operating Expenses | 174,112 | 128,559 | 97,630 | 54,048 | 34,562 |
| Operating Income | 82,759 | 59,479 | 47,744 | 22,597 | 25,494 |
| Other Income | -18,006 | -12,645 | -12,139 | 2,566 | -3,255 |
| Pre-tax Income | 64,753 | 46,834 | 35,605 | 25,163 | 22,239 |
| Income Tax | 19,799 | 15,457 | 13,993 | 6,397 | 9,005 |
| Net Income Continuous | 18,600 | 33,016 | 23,415 | 20,837 | 14,046 |
| Net Income | $42,578 | $31,646 | $23,572 | $21,409 | $14,046 |
| EPS Basic Total Ops | 0.12 | 0.09 | 0.06 | 0.06 | 0.05 |
| EPS Basic Continuous Ops | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| EBITDA(a) | $82,759 | $79,686 | $47,744 | $22,597 | $25,494 |